Sonoma Pharmaceuticals (SNOA) EBT (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly EBT of -$497000.0 for Q1 2026, up 5.87% year-over-year from -$469438.3 in Q1 2025, and up 47.63% quarter-over-quarter from -$949000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) EBT (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' EBT history runs 17 years deep, the most recent figure standing at -$497000.0 for Q1 2026.
- In Q1 2026, EBT rose 5.87% year-over-year to -$497000.0; the TTM figure through Mar 2026 stood at -$3.4 million (down 17.61% YoY), while the FY2026 annual figure was -$3.4 million, down 17.61% from the prior year.
- EBT for Q1 2026 stood at -$497000.0, up from -$949000.0 in the prior quarter.
- The five-year high for EBT was -$463000.0 in Q3 2024, with the low at -$3.3 million in Q1 2022.
- The 5-year median for EBT is -$949000.0 (2025), against an average of -$1.2 million.
- The sharpest annual moves came in 2022 and 2024: EBT tumbled 865.26% in 2022, then jumped 64.33% in 2024.
- Sonoma Pharmaceuticals' EBT stood at -$1.9 million in 2022, then soared by 51.55% to -$923000.0 in 2023, then grew by 0.43% to -$919000.0 in 2024, then slipped by 3.26% to -$949000.0 in 2025, then jumped by 47.63% to -$497000.0 in 2026.
- Business Quant data shows SNOA's EBT at -$497000.0 in Q1 2026, -$949000.0 in Q4 2025, and -$731000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn | -330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -330,000.00 |
| Mar 31, 2026 | -497,000.00 |
| Dec 31, 2025 | -949,000.00 |
| Sep 30, 2025 | -731,000.00 |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -528,000.00 |
| Dec 31, 2024 | -919,000.00 |
| Sep 30, 2024 | -463,000.00 |
| Jun 30, 2024 | -997,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | -923,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -1.44 Mn |
| Dec 31, 2022 | -1.91 Mn |
| Sep 30, 2022 | -917,000.00 |
| Jun 30, 2022 | -922,000.00 |
| Mar 31, 2022 | -3.28 Mn |
| Dec 31, 2021 | -944,000.00 |
| Sep 30, 2021 | -95,000.00 |